What is the effect of alternative summary statistics for communicating risk reduction on decisions about whether to take statins?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN85194921

Enrollment

4800

Registered

2007-05-04

Start date

2003-06-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolaemia (hypothetical scenario) Circulatory System Disorders of lipoprotein metabolism and other lipidaemias

Interventions

Presentations of summary statistic showing evidence of statins' effectiveness in preventing coronary heart disease over ten years. The participants viewed one of the following six presentations: 1.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. At least 18 years of age 2. Fluent in English or Norwegian

Exclusion criteria

Exclusion criteria: Previous participation in this trial

Design outcomes

Primary

Measure	Time frame
Hypothetical treatment decision to take or not to take statins.	—

Secondary

Measure	Time frame
Understanding of and satisfaction with information, and preferred summary statistic.	—

Countries

Canada, Norway, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 4, 2026